AML ETO T821 Gene Rearrangement Quantitative MRD Monitor Test
Introduction
The AML ETO T821 Gene Rearrangement Quantitative MRD Monitor Test is a specialized diagnostic tool designed to assist healthcare providers in monitoring the effectiveness of treatment in patients with certain types of cancers. This test is particularly significant for those diagnosed with Acute Myeloid Leukemia (AML) and aims to detect minimal residual disease (MRD), which is crucial for guiding further treatment decisions.
What the Test Measures
This test quantifies the presence of specific gene rearrangements associated with AML. By measuring the levels of these rearrangements, clinicians can determine how well a patient is responding to treatment and if any cancer cells remain.
Who Should Consider This Test
Patients diagnosed with AML or those who have undergone treatment for this condition should consider the AML ETO T821 Gene Rearrangement Quantitative MRD Monitor Test. Key indicators include:
- Recent diagnosis of AML
- Previous treatment for AML
- Symptoms indicating potential relapse
Benefits of Taking the Test
Undergoing the AML ETO T821 Gene Rearrangement Quantitative MRD Monitor Test offers several benefits, including:
- Accurate monitoring of treatment efficacy
- Early detection of potential relapses
- Informed decision-making for future treatment options
Understanding Your Results
Results from the test will indicate the level of gene rearrangement present in the blood or bone marrow. A higher level may suggest that residual cancer cells remain, while a lower level may indicate a favorable response to treatment. It is essential to discuss results with your healthcare provider to understand their implications fully.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| AML ETO T821 Gene Rearrangement Quantitative MRD Monitor Test | 15,000 KSh | 20,000 KSh |
Sample and Collection Instructions
The test requires a sample of 5 mL (minimum 3 mL) of whole blood or bone marrow collected in a Lavender Top (EDTA) tube. The sample must be shipped refrigerated and should not be frozen. A duly filled MRD Requisition form (Form 22) with historical data is mandatory for processing.
Branches and Booking
We have branches across all major cities in Kenya, making it convenient for you to access our services. To book the AML ETO T821 Gene Rearrangement Quantitative MRD Monitor Test, please call or WhatsApp us at +254711564616. Don’t wait—take control of your health today!
